Cover Image

Cost-Effectiveness of Mobile Health-Based Integrated Care for Atrial Fibrillation: Model Development and Data Analysis

BackgroundMobile health (mHealth) technology is increasingly used in disease management. Using mHealth tools to integrate and streamline care has improved clinical outcomes of patients with atrial fibrillation (AF). ObjectiveThe aim of this study was to investigate the potential clinical and health...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xueyan Luo (Author), Wei Xu (Author), Wai-Kit Ming (Author), Xinchan Jiang (Author), Quan Yuan (Author), Han Lai (Author), Chunji Huang (Author), Xiaoni Zhong (Author)
Format:	Book
Published:	JMIR Publications, 2022-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Costs and clinical consequences of suboptimal atrial fibrillation management
by: Singh SN
Published: (2012)

Cost considerations in the management of atrial fibrillation – impact of dronedarone
by: Khaykin Y, et al.
Published: (2012)

Comorbidity in elderly patients with atrial fibrillation affects the "cost of illness"
by: S. V. Malchikova, et al.
Published: (2019)

Impact of Mobile Health Devices for the Detection of Atrial Fibrillation: Systematic Review
by: Biersteker, Tom E, et al.
Published: (2021)

Does YouTube Provide Qualified Patient Education Videos About Atrial Fibrillation?
by: Chong Luo, et al.
Published: (2022)

Cost of illness of atrial fibrillation: a nationwide study of societal impact
by: Søren Paaske Johnsen, et al.
Published: (2017)

Cost-Effectiveness of Dronedarone and Amiodarone for the Treatment of Chinese Patients With Atrial Fibrillation
by: Mengran Zhang, et al.
Published: (2021)

ANALYSIS OF DIRECT COSTS ASSOCIATED WITH THE USE OF WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION
by: Yu. B. Belousov, et al.
Published: (2016)

Atrial Fibrillation Mechanisms and Treatment
Published: (2013)

Impact of Prolonged Cycle Length Resulting From Conversion of Atrial Fibrillation to Atrial Tachycardia on Ablation Outcome in Persistent Atrial Fibrillation Ablation
by: Jialing He, et al.
Published: (2024)

ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS
by: M. Yu. Gilyarov, et al.
Published: (2016)

ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS
by: M. Yu. Gilyarov, et al.
Published: (2016)

HYPERTHYROIDISM AND ATRIAL FIBRILLATION
by: I. M. Marusenko, et al.
Published: (2017)

Screening for atrial fibrillation
by: Zhenisgul Tlegenova, et al.
Published: (2018)

Atrial Fibrillation Types and Chronic Kidney Disease are Independent Predictors of Atrial Fibrillation Recurrence After Radiofrequency Ablation
by: Mo P, et al.
Published: (2024)

Drug-Induced Atrial Fibrillation / Atrial Flutter
by: O. D Ostroumova, et al.
Published: (2022)

Atrial Fibrillation Basic Research and Clinical Applications
Published: (2012)

The use of oral anticoagulants in patients with atrial fibrillation: cohort study data
by: O. V. Gaisenok, et al.
Published: (2016)

Atrial Fibrillation Termination as a Predictor for Persistent Atrial Fibrillation Ablation: A Systemic Review and Meta-Analysis of Prospective Studies
by: Jialing He, et al.
Published: (2024)

Atrial Fibrillation Diagnosis and Management in the 21st Century
Published: (2022)

Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation
by: Levy Adrian R, et al.
Published: (2006)

Atrial fibrillation following synthetic cannabinoid abuse
by: Tolga Han Efe, et al.
Published: (2017)

The Utility of Speckle Tracking Echocardiographic Parameters in Predicting Atrial Fibrillation Recurrence After Catheter Ablation in Patients with Non-Valvular Atrial Fibrillation
by: Zeng D, et al.
Published: (2024)

Stroke, Dementia and Atrial Fibrillation
Published: (2020)

Epidemiology and Treatment of Atrial Fibrillation
Published: (2020)

New Perspective in Atrial Fibrillation
Published: (2021)

Atrial Fibrillation Secondary to Dehydration
by: Kriti Bhatia
Published: (2014)

GENETIC PREDICTORS OF ATRIAL FIBRILLATION
by: A. V. Kuskaeva, et al.
Published: (2016)

Atrial Fibrillation in Hypertrophic Cardiomyopathy
by: G. A. Ignatenko, et al.
Published: (2021)

Iron deficiency and atrial fibrillation
by: Metin Okşul, et al.
Published: (2018)

ATRIAL FIBROSIS IS A MORPHOLOGICAL BASIS OF ATRIAL FIBRILLATION
by: O. M. Drapkina, et al.
Published: (2015)

ATRIAL FIBROSIS IS A MORPHOLOGICAL BASIS OF ATRIAL FIBRILLATION
by: O. M. Drapkina, et al.
Published: (2015)

Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis
by: Haotian Ma, et al.
Published: (2021)

Healthcare resources and costs associated with nonvalvular atrial fibrillation in Spain: apixaban versus acenocoumarol
by: Josep Comin Colet, et al.
Published: (2023)

Twice-daily rivaroxaban after percutaneous left atrial appendage closure for atrial fibrillation
by: Yang-Qi Pan, et al.
Published: (2024)

An instrument to measure atrial fibrillation knowledge in Chinese patients: validation of the Jessa Atrial fibrillation Knowledge Questionnaire
by: Sijie Chang, et al.
Published: (2023)

The atrial fibrillation paradox -connecting hypertension to atrial disease and stroke
by: Phil Mendys, et al.
Published: (2021)

Sacubitril/Valsartan Improves Left Atrial and Left Atrial Appendage Function in Patients With Atrial Fibrillation and in Pressure Overload-Induced Mice
by: Ya Suo, et al.
Published: (2019)

Honokiol Inhibits Atrial Metabolic Remodeling in Atrial Fibrillation Through Sirt3 Pathway
by: Guang Zhong Liu, et al.
Published: (2022)

Cost-effectiveness of a Telemonitoring Program for Patients With Heart Failure During the COVID-19 Pandemic in Hong Kong: Model Development and Data Analysis
by: Jiang, Xinchan, et al.
Published: (2021)